BioTime (BTX) Announces Second Quarter 2012 Financial Results and Recent Corporate Accomplishments  
8/10/2012 10:49:35 AM

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the second quarter ended June 30, 2012 and highlighted recent corporate accomplishments.